Ebola treatment trial begins in DRC amid $3.6B outbreak cost warning

A clinical trial for Ebola treatments has commenced in the Democratic Republic of Congo as the outbreak continues. The UN has estimated the outbreak could cost Africa up to $3.6 billion in economic impact, elevating the health crisis's significance for businesses and investors operating across affected regions.